ISSN: 2167-0234
Journal of Business & Financial Affairs
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
 
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Are Negative P/E and P/B ratio Firms Different?

George Athanassakos*
Ben Graham Chair in Value Investing, Richard Ivey School of Business, The University of Western Ontario, London, Ontario, N6A 3K7 Canada
*Corresponding Author : George Athanassakos
Ben Graham Chair in Value Investing
Richard Ivey School of Business
The University of Western Ontario
London, Ontario, N6A 3K7 Canada
Tel: (519) 661-4096
E-mail: gathanassakos@ivey.uwo.ca
Received April 17, 2013; Accepted June 01, 2013; Published June 05, 2013
Citation: Athanassakos G (2013) Are Negative P/E and P/B ratio Firms Different? J Bus & Fin Aff 2:109. doi:10.4172/2167-0234.1000109
Copyright: © 2013 Athanassakos G. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Business & Financial Affairs

Abstract

Using separately AMEX, NASDAQ and NYSE stock market data for the period 1968-2011, the purpose of this paper is to examine whether negative multiple firms are different from positive ones by examining the performance of negative P/E or P/B firms and how this performance compared with the most widely examined positive multiples firms. We find that firms with negative multiples are indeed different than firms with positive in that (a) a relatively small number of firms with negative multiples experience high forward stock returns even though the majority of them does not resulting in a large difference between mean and median returns and (b) the small firm-low liquidity effect observed in positive multiple firms is not as clearly observed in the case of negative multiple firms. This indicates that prior academic research was right in excluding negative multiple firms from their analysis as inclusion would have affected the homogeneity of their sample and would have diluted their findings and tests of significance.

Keywords
Financial statement analysis; Positive and negative priceto- earnings; Positive and negative price-to-book
JEL Classification
G12, G14, M41
Introduction
A large body of academic research has examined the performance of firms with different levels of positive price-to-earnings (P/E) or priceto- book (P/B) stocks, but there is not much research with regards to the performance of negative P/E or P/B firms and how this performance compares with the most widely examined positive multiples firms [1-9]. Academic papers, such as the ones referred to above, exclude from their analysis negative P/E or P/B firms. Negative P/E or P/B firms were considered to be different from the positive multiple firms and had to be segregated in order to keep the homogeneity of the sample intact. But are they really different?
Using separately AMEX, NASDAQ and NYSE stock market data for the period 1968-2011, the purpose of this paper is to answer this question by examining the performance of negative P/E or P/B firms and how this performance compares with the most widely examined positive multiples firms.
While previous studies [3-8] derive trailing price to earnings (P/E) and price to book value (P/B) ratios using price as at the end of June of year (t) and earnings per share and book value per share as of December of year (t-1), this study will derive trailing ratios where price is as at the end of April of year (t), given that our sample only include firms that already have reported financials by the end of April of year (t). We see no reason to wait until June given that a stock selection strategy can be implemented at an earlier time.
First, we will examine the performance of positive multiple firms and then that of the negative multiples firms and draw conclusions. Given the implicit assumption made by academic papers to date regarding positive and negative multiple firms, our null hypothesis is that negative and positive multiple firms exhibit similar return and fundamental financial characteristics.
This paper shows that firms with negative multiples are indeed different than firms with positive in that (a) a relatively small number of firms with negative multiples experience high forward stock returns even though the majority of them does not resulting in a large difference between mean and median returns and (b) the small firmlow liquidity effect observed in positive multiple firms is not as clearly observed in the case of negative multiple firms. This indicates that prior academic research was right in excluding negative multiple firms from their analysis as inclusion would have affected the homogeneity of their sample and would have diluted their findings and test of significance.
The rest of the paper is structured as follows. Section 2 discusses the data sources and sample selection. Section 3 reports the empirical results and compares the performance of positive and negative multiples stocks and Section 4 concludes the paper and discusses the implications of findings.
Data and Methodology
Our sample includes all AMEX, NASDAQ, NYSE companies that traded on US Stock Exchanges for the period 1969-2011, as well as their financials for the period 1968-2009.
As in Athanassakos [11], this paper uses data from COMPUSTAT from which earnings per share (E), book value per share (B), shares outstanding, trading volume, stock prices and dividends paid, as well as company financials are obtained, and from which trailing price to earnings (P/E), trailing price to book (P/B), total returns, stock liquidity, market cap and firm fundamentals are derived.1 For the trailing P/E (P/B) ratios, the price (P) is as of the end of April of year (t) and E (B) is the fully diluted annual earnings per share (book value per share) for companies with fiscal year end in year (t-1), as reported in COMPUSTAT. Annual total stock returns are calculated as the price change plus the dividend from May 1 of year (t) to April 30 of year (t+1) over the price in May 1 of year (t).
Firm fundamentals, derived from company financials, are defined as follows: CASH is cash over assets. EBIT MARGIN is EBIT over Revenues (i.e., operating margin). TURNOVER is assets over revenues (times). CURRENT RATIO is the ratio of cash plus short term investments, inventories and accounts receivable to current liabilities (times). DEBT is short and long term debt to equity. EPS GROWTH, EBIT GROWTH and REV GROWTH are the annual growth rates of EPS, EBIT and revenues, respectively for fiscal year (t-1). Market metrics are defined as follows: MARKET CAP is derived by multiplying price per share time’s shares outstanding at the end of April of year (t). LIQUIDITY is the annual stock trading volume of the year prior to May of year (t) over shares outstanding as at April of year (t).
To eliminate likely data errors [10,11], we have excluded firms with P/E values over 500 and P/B values over 30. Finally, to be included in our sample a stock had to have a price over $1 and to have reported financials in COMPUSTAT.
After all aforementioned screenings, the sample with the positive multiples ends up with 90,423 cross sectional-time series (firm-year) observations belonging to a cumulative number of 8,570 unique companies. Of those companies 1,217 are AMEX, 3,244 are NYSE and 4,109 are NASDAQ companies.
The negative multiples sample includes 6,232 firms or 22,133 observations with negative P/E ratios and 927 firms or 2,246 observations with negative P/B ratios over the sample period. For the negative P/E group, 3,564 unique companies (14,332 observations) are NASDAQ companies, 838 are AMEX (2,616 observations) and 1,830 are NYSE (5,185 observations). For the negative P/B group, 294 unique firms (834 observations) are NYSE, 134 are AMEX (339 observations) and 499 are NASDAQ (1,083 observations).
Non-overlapping forward annual stock returns (adjusted for stock splits and stock dividends) are obtained from May 1, 1969 to April 30, 2011. Trailing company fundamentals, as defined earlier, are for the period 1968 to 2009.
Empirical Results
Table 1 and 2 report the summary statistics for key variables of firms with positive multiples (Table 1) and those with negative multiples (Table 2). The tables include the mean, median, minimum and maximum of each variable.
In Table 1, we see that the EBIT margin and turnover for the median positive multiple firm are 9.88% and 0.857, respectively. The median annual growth rates of revenues, EPS and EBIT have all been positive over the sample period. The median firm is not overleveraged as indicated by the debt to equity ratio of .28 and has a market cap is US$182.5 million. Median values for cash to assets and current ratio are 3.7% and 2.1, respectively. Moreover, the median firm trades about 48% of the shares outstanding over the previous year. Finally, the median stock return of firms with positive multiples is 8%.
Comparing Table 1 and 2, we see that firms with negative P/E or P/B have very low or negative median EBIT margin, and EPS, EBIT and revenue growth rates as opposed to a very positive one for firms with positive multiples. Negative P/E or P/B firms also have very low market cap and higher debt, turnover and liquidity (annual trading volume to shares outstanding) than firms with positive multiples. Median tests, reported in Table 2 (Panel C) and based on CHI-SQUARE tests for testing the null hypothesis that median values for the variables of Tables 1 vs. Table 2 (i.e., of positive vs. negative multiple firms) are equal, show the following. Median values of Table 1 variables are statistically different from the median values of same variables in Table 2 (Panel A), with the exception of current ratio and debt, at conventional levels of significance. Moreover, all median values of Table 1 variables are statistically different from the median values of the same variables in Table 2 (Panel B), at conventional levels of significance. Finally, we see that firms with negative P/B also have negative P/E, but not the other way around.
More importantly, there is a very large difference between mean and median returns when firms have negative P/E (21.1% and 0%, respectively) or P/B ratios (30.6% and 6.8%, respectively) vis-à-vis corresponding numbers when firms have positive multiples (16.8% vs. 8%, respectively). Although, on average, returns are much higher for negative P/E (P/B) firms than positive ones, 50% of the negative P/E (P/B) firms experience a return of less than zero (6.81%) as opposed to positive P/E firms whereby 50% of the returns are less than 8%. Not shown here, this is also true when we look at individual exchanges. AMEX firms with negative P/E have a mean return of 9.14% and a median return of -6.98%, NASDAQ firms 21.54% and -3.31% and NYSE firms 25.87% and 9.37%. For negative P/B firms, the mean return for AMEX is 17.5%, for NASDAQ 34.44% and for NYSE 30.54%; the corresponding medians are -3.71%, 5.28% and 11.52%, respectively. Again, not shown here, the mean and median return Table icons by exchange for the positive multiples firms in the sample are: 12.7% vs. 2.42% for AMEX, 18.5% vs. 5.4% for NASDAQ and 16.7% vs. 10.4% for NYSE stocks2.
Firms with negative multiples are thus different than firms with positive multiples and hence our null hypothesis is rejected. As we see in Table 2, negative P/E or P/B firms experience, on average, high stock returns even though their medians are relatively low. This indicates that while some low P/E or P/B value firms have high returns the majority of such firms do not, resulting in much larger differences between mean and median returns than firms with positive multiples, both for the total sample and by exchange. The implication of this is that one can find real gems within negative P/E or P/B firms but he/she needs to be extremely cautious as the majority of such firms are anything but. In other words, prior academic research was right in excluding negative multiple firms from their analysis as inclusion would have affected the homogeneity of their sample.
Further analysis also shows that negative P/E (P/B) firms are different than positive P/E (P/B) firms in another dimension as is shown in Table 3 (Panels A and B). While smaller and less liquid positive P/E (P/B) firms tend to perform unequivocally economically and statistically better than larger/more liquid firms [12-14], for negative P/E (P/B) firms the evidence is not as clear cut as the bigger and more liquid firms seem to earn median annual returns comparable to the smaller and less liquid firms. The markets seem to reward liquidity and size more when it comes to negative P/E (P/B) firms than when it comes to positive multiple firms. Market participants may view negative P/E or P/B firms as riskier thus preferring to focus on the safer larger/more liquid firms among them, which enable them to exit quickly if the need arises, resulting in higher than normal returns for these vs. equivalent positive multiple firms. This further exemplifies the importance of segregating negative from positive multiple firms in related research as inclusion would undermine the clarity and generality of findings and dilute the significance of empirical evidence.
Conclusions
Using separately AMEX, NASDAQ and NYSE stock market data for the period 1968-2011, the purpose of this paper was to examine whether negative multiple firms were different from positive ones by examining the performance of negative P/E or P/B firms and how this performance compared with the most widely examined positive multiples firms. We found that firms with negative multiples are indeed different than firms with positive in that (a) a relatively small number of firms with negative multiples experience high forward stock returns even though the majority of them does not resulting in a large difference between mean and median returns and (b) the small firmlow liquidity effect observed in positive multiple firms is not as clearly observed in the case of negative multiple firms. This indicates that prior academic research was right in excluding negative multiple firms from their analysis as inclusion would have affected the homogeneity of their sample and would have diluted their findings and tests of significance.
1There is no survivorship bias in the COMPUSTAT data employed in this paper as dead/merged companies are included in our sample.
2We also repeated the analysis by excluding the upper 10% and bottom 10% of the ranked data and found that the results were not materially different for all variables examined both in terms of mean and median values.
References
Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 11333
  • [From(publication date):
    June-2013 - Jul 26, 2016]
  • Breakdown by view type
  • HTML page views : 7586
  • PDF downloads :3747
 
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version